Lutz, FL, United States of America

Ashleigh Brooke Bachman


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Drug Delivery: The Contributions of Ashleigh Brooke Bachman

Introduction

Ashleigh Brooke Bachman is a prominent inventor based in Lutz, Florida, known for her innovative work in the field of drug delivery systems. With a focused approach on enhancing the efficacy of pharmaceuticals, she has made significant strides in developing novel formulations that show promise in improving therapeutic outcomes.

Latest Patents

Bachman holds a patent for her groundbreaking invention titled "Menthol-based nanoparticles for drug delivery." This patent pertains to formulations comprising poly(menthyl acrylate) nanoparticles, which incorporate at least one active ingredient contained in a variety of hydrophobic carriers and are dispersed in an aqueous medium. Furthermore, the patent elaborates on methods of polymerization of these drug-loaded nanoparticles made up of methyl acrylate monomers in an aqueous emulsion. This innovation represents a substantial advancement in drug delivery technology.

Career Highlights

Bachman is affiliated with the University of South Florida, where she has been able to collaborate with fellow researchers and contribute to advancements in biomedical sciences. Her work not only underscores her dedication to research and development but also highlights her commitment to creating meaningful solutions in the healthcare sector.

Collaborations

Throughout her career, Bachman has collaborated with notable colleagues, including Edward Turos and Faeez Mahzamani. These collaborations have fostered an environment of creativity and innovation, leading to the successful exploration and development of effective drug delivery systems.

Conclusion

Ashleigh Brooke Bachman stands out as an inventive force in the realm of drug delivery technologies. Her innovative approach to creating menthol-based nanoparticles has opened new avenues for effective pharmaceutical applications. As she continues her research at the University of South Florida, the impact of her work will likely resonate across the healthcare industry, paving the way for more effective treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…